Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment - findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial
Author(s): Hawkey CJ, Weinstein WM, Stricker K, Murphy V, Richard D, Krammer G, et al
Alimentary Pharmacology & Therapeutics. 2008 May;27(9):838-45.
NIHR Acknowledged: Yes
|Professor Christopher Hawkey||Christopher Hawkey is Professor of Gastroenterology at the Nottingham Digestive Diseases Centre. His main interests are in the field of non-steroid anti-inflammatory drugs and inflammatory bowel disease. In both areas his approach is to try to identify…|